Hydromorphone Hydrochloride · #5 of 35 active shortages by FDA posting duration
Brand: HYDROMORPHONE HYDROCHLORIDE
FDA lists Hydromorphone Hydrochloride as Active Shortage (Hospira, Inc., a Pfizer Company).
Availability on file: Available
Hydromorphone Hydrochloride Injection: Active Shortage
Available 26 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Hydromorphone Hydrochloride Injection
- Manufacturer
- Hospira, Inc., a Pfizer Company
- Dosage Form
- Injection
- Presentation
- Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0409-2634-01)
- Package NDC
- 0409-2634-01
Status & Timeline
- Status
- Active Shortage
- Availability
- Available
- First Reported
- Oct 31, 2017
- Last Updated
- Mar 13, 2026
- Therapeutic Category
- Analgesia/Addiction
Row fields from the FDA Drug Shortages database via openFDA.
Full Drug Profile
hydromorphone
Side effects, interactions, warnings & more
Nearby, Other Hydromorphone Shortage Records
Hydromorphone Hydrochloride Injection
Fresenius Kabi USA, LLC
Injection
Hydromorphone Hydrochloride Injection
Fresenius Kabi USA, LLC
Injection
Hydromorphone Hydrochloride Injection
Fresenius Kabi USA, LLC
Injection
Hydromorphone Hydrochloride Injection
Fresenius Kabi USA, LLC
Injection
Hydromorphone Hydrochloride Injection
Fresenius Kabi USA, LLC
Injection
Hydromorphone Hydrochloride Injection
Fresenius Kabi USA, LLC
Injection